Workflow
Biofrontera(BFRI) - 2022 Q4 - Earnings Call Transcript
BFRIBiofrontera(BFRI)2023-03-09 12:09

Fred Leffler - CFO Bruce Jackson - The Benchmark Company Unidentified Company Representative With that, I'd like to turn the call over to Erica Monaco. Erica? While we continue to invest in our commercial team, we expect that the selling expense growth should be generally in line with revenue growth in the short term. Longer term, we expect SG&A leverage as these expenses will grow slower than revenues as we reach our target commercial structure. Adjusted EBITDA was negative $4.4 million for the quarter com ...